Amelioration of rat adjuvant-induced arthritis by Met-RANTES.

@article{Shahrara2005AmeliorationOR,
  title={Amelioration of rat adjuvant-induced arthritis by Met-RANTES.},
  author={Shiva Shahrara and Amanda E. I. Proudfoot and James M. Woods and Jeffrey H. Ruth and Mohammad A. Amin and Christy C. Park and Christian S Haas and Richard M. Pope and G. Kenneth Haines and Yuan yuan Zha and Alisa Erika Koch},
  journal={Arthritis and rheumatism},
  year={2005},
  volume={52 6},
  pages={1907-19}
}
OBJECTIVE CC chemokines and their receptors play a fundamental role in trafficking and activation of leukocytes at sites of inflammation, contributing to joint damage in rheumatoid arthritis. Met-RANTES, an amino-terminal-modified methionylated form of RANTES (CCL5), antagonizes the binding of the chemokines RANTES and macrophage inflammatory protein 1alpha (MIP-1alpha; CCL3) to their receptors CCR1 and CCR5, respectively. The aim of this study was to investigate whether Met-RANTES could… CONTINUE READING
53 Citations
41 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Evaluation of a small molecule CCR2 antagonist in a rat model of rheumatoid arthritis [abstract]. Arthritis Rheum 2004;50 (Suppl 9):S369

  • CM Brodmerkel, R Collins, L Hall, D Hertel, R Stewart, A Wang
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…